Page last updated: 2024-08-23

1-deoxynojirimycin and Adult Sandhoff Disease

1-deoxynojirimycin has been researched along with Adult Sandhoff Disease in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (11.76)18.2507
2000's11 (64.71)29.6817
2010's4 (23.53)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hopkin, RJ; Hufnagel, SB; Jefferies, JL; Karl, G; Pabón, LA; Prada, CE; Serrano, NC; Villamizar-Schiller, IT1
Dekomien, G; Lefeber, DJ; Morava, E; Wevers, RA; Willemsen, MA; Wortmann, SB1
Berg, JE; Tallaksen, CM1
Baek, RC; Bronson, RT; Butters, TD; Denny, CA; Heinecke, KA; Kim, YP; Loh, KS; Platt, FM; Seyfried, TN1
Guitton, J; Masciullo, M; Modoni, A; Ricci, E; Santoro, M; Silvestri, G; Tonali, P1
Arthur, JR; Lee, JP; Seyfried, TN; Snyder, EY1
Butters, TD; Dwek, RA; Jeyakumar, M; Platt, FM1
Butters, TD; d'Azzo, A; Dwek, RA; Elliot-Smith, E; Jeyakumar, M; Perry, VH; Platt, FM; Smith, DA; Thomas, R; van der Spoel, AC1
Futerman, AH; Jeyakumar, M; Lloyd-Evans, E; Pelled, D; Platt, FM; Riebeling, C1
Andersson, U; Borja, MC; Butters, TD; Dwek, RA; Jeyakumar, M; Platt, FM; Smith, D1
Borja, MC; Butters, TD; Dwek, RA; Jeyakumar, M; Neville, DC; Platt, FM; Smith, DA; Williams, IM1
Baek, RC; Butters, TD; Clark, D; Clarke, J; Dwek, RA; Fu, G; Gonzalez, R; Jeyakumar, M; Lee, JP; Lee, PJ; Lipton, SA; McKercher, S; Meerloo, J; Muller, FJ; Park, KI; Platt, FM; Rose, H; Schwartz, P; Seyfried, TN; Snyder, EY; Takahashi, H; Tong, G; Wenger, D1
Jakóbkiewicz-Banecka, J; Wegrzyn, A; Wegrzyn, G1
Baek, RC; Kasperzyk, JL; Platt, FM; Seyfried, TN1
Chavany, C; Jendoubi, M1
Butters, TD; Cortina-Borja, M; Dwek, RA; Hunnam, V; Jeyakumar, M; Perry, VH; Platt, FM; Proia, RL1
Butters, TD; Cortina-Borja, M; Dwek, RA; Jeyakumar, M; Norflus, F; Perry, VH; Platt, FM; Proia, RL; Tifft, CJ1

Reviews

3 review(s) available for 1-deoxynojirimycin and Adult Sandhoff Disease

ArticleYear
Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis.
    Neuropathology and applied neurobiology, 2002, Volume: 28, Issue:5

    Topics: 1-Deoxynojirimycin; Animals; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Disease Models, Animal; G(M2) Ganglioside; Gangliosides; Glucosylceramides; Glucosyltransferases; Glycosphingolipids; Humans; Lysosomal Storage Diseases; Lysosomes; Mice; Models, Biological; Models, Chemical; Morpholines; Sandhoff Disease; Tay-Sachs Disease; Treatment Outcome

2002
Substrate deprivation therapy: a new hope for patients suffering from neuronopathic forms of inherited lysosomal storage diseases.
    Journal of applied genetics, 2007, Volume: 48, Issue:4

    Topics: 1-Deoxynojirimycin; Animals; Enzyme Inhibitors; Gaucher Disease; Genistein; Humans; Lysosomal Storage Diseases; Lysosomes; Mucopolysaccharidosis III; Niemann-Pick Diseases; Sandhoff Disease; Tay-Sachs Disease

2007
Biology and potential strategies for the treatment of GM2 gangliosidoses.
    Molecular medicine today, 1998, Volume: 4, Issue:4

    Topics: 1-Deoxynojirimycin; Adolescent; Adult; Animals; beta-N-Acetylhexosaminidases; Bone Marrow Transplantation; Cats; Cell Transplantation; Child; Disease Models, Animal; Dogs; G(M2) Ganglioside; Genetic Therapy; Genetic Vectors; Glycolipids; HIV; Humans; Infant; Lysosomes; Mice; Mice, Knockout; Neurons; Phenotype; Point Mutation; Rats; Sandhoff Disease; Swine; Tay-Sachs Disease; Transplantation, Homologous

1998

Other Studies

14 other study(ies) available for 1-deoxynojirimycin and Adult Sandhoff Disease

ArticleYear
Neurological and cardiac responses after treatment with miglustat and a ketogenic diet in a patient with Sandhoff disease.
    European journal of medical genetics, 2015, Volume: 58, Issue:3

    Topics: 1-Deoxynojirimycin; Child; Child, Preschool; Diet, Ketogenic; Humans; Male; Sandhoff Disease

2015
Substrate deprivation therapy in juvenile Sandhoff disease.
    Journal of inherited metabolic disease, 2009, Volume: 32 Suppl 1

    Topics: 1-Deoxynojirimycin; Adolescent; Child, Preschool; Disease Progression; Enzyme Inhibitors; Glucosyltransferases; Hexosaminidase B; Humans; Male; Mutation; Sandhoff Disease

2009
Miglustat therapy in juvenile Sandhoff disease.
    Journal of inherited metabolic disease, 2009, Volume: 32 Suppl 1

    Topics: 1-Deoxynojirimycin; Adolescent; beta-Hexosaminidase beta Chain; Cerebellum; Child, Preschool; Depression; Disease Progression; Electroconvulsive Therapy; Enzyme Inhibitors; Glucosyltransferases; Humans; Male; Mutation; Sandhoff Disease

2009
Restricted ketogenic diet enhances the therapeutic action of N-butyldeoxynojirimycin towards brain GM2 accumulation in adult Sandhoff disease mice.
    Journal of neurochemistry, 2010, Volume: 113, Issue:6

    Topics: 1-Deoxynojirimycin; 3-Hydroxybutyric Acid; Analysis of Variance; Animals; beta-N-Acetylhexosaminidases; Blood Glucose; Body Weight; Brain; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Diet, Ketogenic; Eating; G(M2) Ganglioside; Lipid Metabolism; Mice; Mice, Knockout; Myelin Sheath; Purkinje Cells; Sandhoff Disease

2010
Substrate reduction therapy with miglustat in chronic GM2 gangliosidosis type Sandhoff: results of a 3-year follow-up.
    Journal of inherited metabolic disease, 2010, Volume: 33 Suppl 3

    Topics: 1-Deoxynojirimycin; Disease Progression; Enzyme Inhibitors; Glucosyltransferases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Weakness; Muscular Atrophy, Spinal; Neurologic Examination; Predictive Value of Tests; Sandhoff Disease; Time Factors; Treatment Outcome

2010
Therapeutic effects of stem cells and substrate reduction in juvenile Sandhoff mice.
    Neurochemical research, 2012, Volume: 37, Issue:6

    Topics: 1-Deoxynojirimycin; Animals; beta-N-Acetylhexosaminidases; G(M2) Ganglioside; Hexosaminidase B; Mice; Neural Stem Cells; Sandhoff Disease

2012
Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis.
    Brain : a journal of neurology, 2003, Volume: 126, Issue:Pt 4

    Topics: 1-Deoxynojirimycin; Animals; Antigens, CD; Apoptosis; Biomarkers; Blood-Brain Barrier; Cytokines; Enzyme Inhibitors; Gangliosidoses; Gangliosidoses, GM2; Gangliosidosis, GM1; Genes, MHC Class II; Immunohistochemistry; Inflammation; Mice; Sandhoff Disease; Tay-Sachs Disease

2003
Inhibition of calcium uptake via the sarco/endoplasmic reticulum Ca2+-ATPase in a mouse model of Sandhoff disease and prevention by treatment with N-butyldeoxynojirimycin.
    The Journal of biological chemistry, 2003, Aug-08, Volume: 278, Issue:32

    Topics: 1-Deoxynojirimycin; Adenosine Triphosphate; Animals; Blotting, Western; Brain; Calcium; Calcium-Transporting ATPases; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Enzyme Inhibitors; G(M2) Ganglioside; Gangliosides; Genotype; Glycolipids; Hippocampus; Kinetics; Lipid Metabolism; Mice; Mice, Transgenic; Microsomes; Neurons; Reverse Transcriptase Polymerase Chain Reaction; Sandhoff Disease; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Spectrophotometry; Thapsigargin; Time Factors

2003
Improved outcome of N-butyldeoxygalactonojirimycin-mediated substrate reduction therapy in a mouse model of Sandhoff disease.
    Neurobiology of disease, 2004, Volume: 16, Issue:3

    Topics: 1-Deoxynojirimycin; Animals; Behavior, Animal; beta-N-Acetylhexosaminidases; Body Weight; Brain; Disease Models, Animal; Female; Gangliosides; Life Expectancy; Liver; Male; Mice; Mice, Mutant Strains; Sandhoff Disease

2004
NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
    Annals of neurology, 2004, Volume: 56, Issue:5

    Topics: 1-Deoxynojirimycin; Age Factors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Behavior, Animal; Blotting, Western; Brain; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Drug Synergism; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Glutathione; Histocompatibility Antigens Class II; Immunohistochemistry; Isoenzymes; Lipid Peroxidation; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Psychomotor Performance; Sandhoff Disease; Spinal Cord; Survival Rate; Time Factors; Vitamin A

2004
Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease.
    Nature medicine, 2007, Volume: 13, Issue:4

    Topics: 1-Deoxynojirimycin; Animals; beta-N-Acetylhexosaminidases; Brain; Embryonic Stem Cells; Humans; Immunohistochemistry; Mice; Mice, Knockout; Microglia; Neurons; Patch-Clamp Techniques; Sandhoff Disease; Stem Cell Transplantation

2007
N-butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice.
    Neurochemistry international, 2008, Volume: 52, Issue:6

    Topics: 1-Deoxynojirimycin; Animals; Animals, Newborn; beta-Hexosaminidase alpha Chain; Brain; Brain Chemistry; Disease Models, Animal; Down-Regulation; G(M2) Ganglioside; Gangliosides; Glycosphingolipids; Mice; Mice, Knockout; Nerve Degeneration; Neuraminidase; Sandhoff Disease; Treatment Outcome

2008
Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, May-25, Volume: 96, Issue:11

    Topics: 1-Deoxynojirimycin; Aging; Animals; Apoptosis; Behavior, Animal; beta-N-Acetylhexosaminidases; Brain; Dentate Gyrus; Enzyme Inhibitors; Female; Genes, Recessive; Glycoside Hydrolase Inhibitors; Glycosphingolipids; Hexosaminidase B; Life Expectancy; Liver; Mice; Mice, Mutant Strains; Motor Activity; Sandhoff Disease

1999
Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation.
    Blood, 2001, Jan-01, Volume: 97, Issue:1

    Topics: 1-Deoxynojirimycin; Animals; beta-N-Acetylhexosaminidases; Bone Marrow Transplantation; Brain; Diagnostic Techniques, Neurological; Disease Models, Animal; Enzyme Inhibitors; Glycosphingolipids; Hexosaminidase B; Mice; Sandhoff Disease; Spinal Cord; Survival Rate

2001